Health

RedHill Biopharma’s Opaganib Demonstrates Strong Inhibition of COVID-19 Delta Variant

Opaganib demonstrated strong inhibition of COVID-19 Delta variant in a human bronchial epithelial cells model, adding to prior data demonstrating potent inhibition of all COVID-19 variants tested to date    Opaganib’s unique, host-targeted, dual antiviral and anti-inflammatory approach to combatting COVID-19 is expected to maintain effect against other emerging variants The global 475-patient Phase 2/3 […]

thaipr.net

30 ส.ค. 64

RedHill Biopharma Reports Second Quarter 2021 Financial Results and Operational Highlights

– Achieved record quarterly revenues of $21.5 million for Q2/2021, 4.5% increase from Q1/2021 despite challenging market conditions; Cash balance 1  of approximately $71.5 million as of June 30, 2021 – Record Talicia® quarterly prescription volume up more than 10%; Movantik® quarterly new prescriptions up 5.6%; Talicia and Movantik coverage expanded to 8 and 9 out of 10 commercially insured Americans, […]

thaipr.net

30 ส.ค. 64

ASEAN-focused dental group, Oracare Group, formed with plans to accelerate expansion across Southeast Asia

Singapore based Oracare Group (“Oracare”), one of the largest dental groups in Southeast Asia, is the new holding company and international brand for a collection of successful national dental groups. Already present in 3 SE Asian countries, the group has ambitious plans for continuing its expansion across the region, despite challenges from the COVID-19 pandemic. Oracare  currently […]

thaipr.net

27 ส.ค. 64

Sai Life Sciences becomes a signatory of the United Nations Global Compact (UNGC)

Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organization (CRO/ CDMO), today announced that it has become a signatory of the United Nations Global Compact (UNGC), the world’s largest sustainability initiative. As a signatory, Sai Life Sciences has committed itself to adopting the Ten Principles of the UNGC on human rights, labour, environment and […]

thaipr.net

26 ส.ค. 64

Athos Therapeutics Announces Research Collaboration with Cleveland Clinic to Advance Precision Medicine in Inflammatory Bowel Disease

Athos to perform a molecular analysis of patient samples from the Cleveland Clinic Athos Therapeutics, Inc., a late preclinical stage biotechnology company pioneering the development of first-in-class precision therapeutics for patients with immune-mediated diseases, announced today a comprehensive Master Research Agreement for a collaborative project on Inflammatory Bowel Disease (IBD) with Cleveland Clinic in Cleveland, […]

thaipr.net

25 ส.ค. 64

RedHill Biopharma Announces Two New U.S. Patents Covering Opaganib for Ebola Virus and RHB-104 for Crohn’s

U.S. patents for opaganib combination for the treatment of Ebola virus disease provides patent protection until 2035 Opaganib’s 475-patient global Phase 2/3 study in severe COVID-19 approaching completion with upcoming top-line results Opaganib also undergoing two oncology Phase 2 U.S. studies as well as several development programs for inflammatory and viral indications, including Ebola Continued […]

thaipr.net

24 ส.ค. 64

JW Therapeutics Announces Strategic Partnership with MediTrust Health

JW Therapeutics (HKEx: 2126), an innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy, today announced that it has entered into a strategic partnership with MediTrust Health. Leveraging the respective business advantages, both parties plan to strengthen cooperation in supplementary medical insurance and health insurance policy, to relieve the payment burden of patients […]

thaipr.net

20 ส.ค. 64

Sai Life Sciences opens new Discovery Biology facility at its integrated R&D campus in Hyderabad, India

Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organization (CRO-CDMO), today announced the opening of a new biology facility at its integrated R&D campus in Hyderabad, India. The facility marks an important milestone in the journey of positioning itself as a differentiated player in Discovery Biology. Making the announcement, CEO & Managing Director of Sai Life […]

thaipr.net

20 ส.ค. 64

MedAlliance Announces Enrollment of First Patient in Erectile Dysfunction Feasibility Study with Sirolimus Drug-Eluting Balloon

MedAlliance has announced enrollment of the first patient in an erectile dysfunction (ED) feasibility study with its sirolimus drug-eluting balloon [DEB]. This occurred at the University of Rome Tor Vergata, Italy, under the direction of the study’s Principal Investigator, Professor of Cardiovascular Interventional Pathology Giuseppe Sangiorgi. The aim of the study is to assess the […]

thaipr.net

19 ส.ค. 64
1 … 102 103 104 105 106 … 130

Copyright © 2025 Dataxet Limited (บริษัท ดาต้าเซ็ต จำกัด). All Rights Reserved.